Andrea Recordati

Biography

Andrea Recordati holds a Bachelor of Arts in Medieval and Modern History at the Royal Holloway and Bedford New College of the University of London. From September 1995 to March 1998 he participated in the SmithKline Beecham Management Access Program in the United Kingdom, starting as Assistant Product Manager in Consumer Healthcare and then serving as a medical informant in Essex for a year, until becoming Project Manager responsible for the development and implementation of an innovative marketing initiative by SmithKline Beecham. He joined Recordati in 1998, holding the position of Project Leader for a project aimed at improving the productivity of the Sales Forces and the best use of marketing investments. Also in April 1998 he joined the Company's Board of Directors. In 1999 he was given responsibility for the Pharmaceutical Business Development function. In March 2002, the Lercanidipine Business Unit was established, of which he was appointed Head of Department. Since November 2002 he has been given responsibility for the set-up of the Recordati Ireland subsidiary and the related industrial plant, and subsequently for the set-up of the branch in the United Kingdom. In August 2007, the Department for North and Central Europe was established, of which he was appointed Head of Department and subsequently extended to include all Western European companies (2010). In 2011 he was appointed General Manager of the International Pharmaceutical Division. In 2013 he became Chief Operating Officer, taking over the management of the Group's commercial and production activities. Andrea Recordati holds a Bachelor of Arts in Medieval and Modern History at the Royal Holloway and Bedford New College of the University of London. From September 1995 to March 1998 he participated in the SmithKline Beecham Management Access Program in the United Kingdom, starting as Assistant Product Manager in Consumer Healthcare and then serving as a medical informant in Essex for a year, until becoming Project Manager responsible for the development and implementation of an innovative marketing initiative by SmithKline Beecham. He joined Recordati in 1998, holding the position of Project Leader for a project aimed at improving the productivity of the Sales Forces and the best use of marketing investments. Also in April 1998 he joined the Company's Board of Directors. In 1999 he was given responsibility for the Pharmaceutical Business Development function. In March 2002, the Lercanidipine Business Unit was established, of which he was appointed Head of Department. Since November 2002 he has been given responsibility for the set-up of the Recordati Ireland subsidiary and the related industrial plant, and subsequently for the set-up of the branch in the United Kingdom. In August 2007, the Department for North and Central Europe was established, of which he was appointed Head of Department and subsequently extended to include all Western European companies (2010). In 2011 he was appointed General Manager of the International Pharmaceutical Division. In 2013 he became Chief Operating Officer, taking over the management of the Group's commercial and production activities.

Research Interest

biochemical / microbiological research and the biochemical / fermentative production site